Reset all filters

  • ALBAND STEPHANIE PICTURE

Stephanie Alband

United States of America
MSBA
Date | Session | Role

15 March/MC | Session 5B - INCA | Moderator
Discipline
Patient / Patient Advocat
Institution
International Neuroendocrine Cancer Alliance (INCA)
Position
President
Main Interest
  • patient participation in improving clinical care and collaborating in research
I have no potential conflict of interest to declare.
  • AMBROSINI VALENTINA PICTURE

Valentina Ambrosini

Italy
Associate Professor, PhD
Date | Session | Role

13 March/PG | Session A | Speaker
Discipline
Nuclear medicine
Institution
Alma Mater Studiorum, University of Bologna, Italy IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Position
Associate Professor in nuclear medicine, full-time employed physician
Main Interest
  • PET/CT in NEN
  • PET/CT with FDG and non-FDG radiopharmaceuticals
  • PET/CT in oncology
Receipt of honoraria or consultation fees: SPEAKERS honoraria from
ESMIT/EANM/ESMOELMAACADEMY in the last 5years; honoraria from cineca.
  • Bartsch

Detlef Bartsch

Germany
Dr. med.
Date | Session | Role

14 March/MC | Session 4A | Moderator
Discipline
Surgery
Institution
Dept. Visceral-, Thoracic- and Vascular Surgery Philipps-University Marburg
Position
Chairman
Main Interest
  • Surgery of small intestine NEN and pNEN
  • Surgery of anaplastic thyroid cancer
I have no potential conflict of interest to declare.
  • Baudin, Eric

Eric Baudin

France 
MD, PhD
Date | Session | Role

13 March/PG | Moderator

13 March/PG | Session A | Speaker
Discipline
Endocrine-Oncology
Institution
Institut Gustave Roussy
Position
Head of the Endocrine Oncology Unit
Main Interest
  • Neuroendocrine neoplasms
  • Adrenal cancer
  • Thyroid cancer
- Receipt of grants/research supports: Novartis, HRA; Pfizer provided Sunitinib and Placebo for a study
- Receipt of honoraria or consultation fees: Ipsen , Novartis, AAA,
Pfizer, Hutchinson Ph
- Other support (please specify): Support for attenting meetings and/or travel: HRA, Novartis, Enterome; Coordinator of the French ENDOCAN network
  • BEGUM NEHARA PICTURE

Nehara Begum

Germany
Dr. med. habil.
Date | Session | Role

13 March/PG | Session A | Moderator
Discipline
Surgery
Institution
Johannes-Wesling-Klinikum Minden, Germany
Position
Leading consultant of the NEN-Center Minden, Secretary of the German NET-Registry
Main Interest
  • Neuroendocrine CUP-Syndrome
  • Palliative Primary Resection in SI-NEN
  • Outcome after Surgery in NEN
Guest speaker for Company Advanced Pharma
Travel grants from Ipsen Pharma
  • BERNHARDT PETER PICTURE

Peter Bernhardt

Sweden
Professor
Date | Session | Role

13 March/BS | Session 4 | Moderator
Discipline
Senior medical physicist
Institution
Sahlgrenska Academy
Position
Professor
Main Interest
  • Dosimetry
  • Radiobiology
  • SPECT reconstructions
Receipt consultation fees: ITM and Affibody. Stock stakeholder: Theravision AB.
  • BHANDARI PRADEEP

Pradeep Bhandari

United Kingdom
MD
Date | Session | Role

14 March/MC | Session 4A | Speaker
Discipline
Gastroenterology
Institution
Portsmouth hospitals university NHS trust
Position
Professor
Main Interest
  • Endoscopic resection
  • BORBATH IVAN PICTURE

Ivan Borbath

Belgium
Prof
Date | Session | Role

13 March/PG | Session B | Speaker
Discipline
Gastroenterology
Institution
Cliniques universitaires Saint-Luc (UCLouvain)
Position
Chef de clinique
Main Interest
  • Clinical research in pancreatic adenocarcinoma, in biliary tract cancer, in hepatocellular carcinoma, in NET
  • Former lead of the ENETS registry, current co-lead of the belgian registry "DNET"
Receipt of grants/research supports: SERVIER
Receipt of honoraria or consultation fees: IPSEN, ROCHE, ASTRA ZENECA
  • Borre APP

Mette Borre

Denmark
RD
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Moderator
Discipline
Nurse
Institution
Department of Hepatology and Gastroenterology, ENETS Center of Excellence, Aarhus University Hospital, Denmark
Position
Registrered Dietician
Main Interest
  • Neuroendocrine cancer
  • Nutrition
  • Quality of life for my patients
I have no potential conflict of interest to declare.
  • Brabander 19

Tessa Brabander

Netherlands
MD, PhD
Date | Session | Role

15 March/MC | Session 5A | Speaker
Discipline
Nuclear medicine
Institution
Erasmus MC
Position
Nuclear medicine physician
Main Interest
  • Peptide receptor radionuclide therapy
  • Functional imaging
- Receipt of grants/research support: AAA/Novartis
- Receipt of honoraria or consultation fees: AAA/Novartis
  • BUONAGURO LUIGI PICTURE

Luigi Buonaguro

Italy
M.D.
Date | Session | Role

13 March/BS | Session 2 | Speaker
Discipline
Tumor & cell biology
Institution
National Cancer Institute - IRCCS PASCALE - Naples IT
Position
Unit Director
Main Interest
  • Cancer vaccine development in liver cancer
  • Antigen identification in sarcoma
I have no potential conflict of interest to declare.
  • BUZAS EDIT-I PICTURE

Edit Buzás

Hungary
MD, PhD
Date | Session | Role

13 March/BS | Session 2 | Speaker
Discipline
immunology
Institution
Semmelweis University, HCEMM-SU and HUN-REN-SU Budapest, Hungary
Position
Professor and Department Head
Main Interest
  • cell biology
  • extracellular vesicles
  • extracellular particles
I have no potential conflict of interest to declare.
  • CAPDEVILA JAUME PICTURE

Jaume Capdevila

Spain
MD, PhD
Date | Session | Role

13 March/PG | Session D | Speaker & Panellist
Discipline
Oncology
Institution
Vall Hebron University Hospital and Vall Hebron Institute of Oncology
Position
Attending Physician and Clinical and Translational Researcher
Main Interest
- Receipt of honoraria or consultation fees: Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen
Technologien; Lilly; Merck Serono; Novartis;
Pfizer; Roche/Genentech; Sanofi
- Participation in a company sponsored speaker’s Bureau: Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technol.; Lilly; Merck Serono; Novartis; Pfizer.; Sanofi
- Other support (please specify): Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
  • CAPLIN MARTYN PICTURE

Martyn Caplin

United Kingdom
PROFESSOR
Date | Session | Role

13 March/PG | Session D | Moderator

14 March/MC | Roundtable | Panellist

15 March/MC | Session 5B - INCA | Speaker
Discipline
Gastroenterology
Institution
Royal Free Hospital London
Position
Professor of Gastroenterology and Neuroendocrine Cancer
Main Interest
  • Translational Neuroendocrine Tumour Research - mesenetric fibrosis/desmoplasia
  • Peptide receptor expression in NETs
  • Peptide Receptor Radioligand Therapy
Receipt of grants/research supports: AAA-NOVARTIS; IPSEN
Receipt of honoraria or consultation fees: AAA-NOVARTIS; IPSEN; PFIZER, INCA
Participation in a company sponsored speaker’s
bureau: AAA-NOVARTIS; IPSEN; PFIZER, INCA
  • CASTANO JUSTO-P PICTURE

Justo P. Castaño

Spain
Bs, MSc, PhD
Date | Session | Role

13 March/BS | Session 3 | Moderator

15 March/MC | Session 6 | Speaker
Discipline
Tumor & cell biology
Institution
Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/ University of Cordoba
Position
Professor and PI
Main Interest
  • Deciphering the role of splicing and RNA biology in Pancreatic, GI and Lung NETs
  • Somatostatin and its receptors in NETs
- Receipt of grants/research supports: IPSEN
- Receipt of honoraria or consultation fees: Endocrine Oncology EiC (Bioscientifica) / Speaker fees or travel support: lPSEN, ADACAP (Novartis), Medscape (prlME Oncology)
  • CHANDLER CHRIS PICTURE

Chris Chandler

United Kingdom
BSc MBBS FRCS(SN)
Date | Session | Role

13 March/PG | Session D | Panellist
Discipline
Surgery
Institution
Kings College Hospital London
Position
Consultant Adult and Paediatric Neurosurgeon
Main Interest
  • Neuro-Oncology
  • Paediatric Neurosurgery
I have no potential conflict of interest to declare.
  • Chotai de Lima

Yasmin Chotai de Lima

United Kingdom
M.Sc, RD
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Moderator
Discipline
Dietitian
Institution
Royal Free Hospital
Position
Clinical Lead Dietitian
Main Interest
  • Interested in nutrition and NETs. Currently working on collaboration with other Specialist Dietitians producing guidance on nutrition and NETs.
Participation in a company sponsored speaker’s bureau: Have previously spoken at Ipsen (Educational Exchange for Nurses and AHPs)
  • Christ

Emanuel Christ

Switzerland
Prof, MD, PhD
Date | Session | Role

13 March/PG | Session B | Speaker
Discipline
Endocrinology
Institution
University Hospital of Basel, Switzerland
Position
Head of Interdisciplinary Endocrinology
Main Interest
  • Theranostics in NET (new ligands, new radioisotopes) - translational research
  • Diagnostic tests in secreting NET
  • Hypopituitarism
- Receipt of grants/research supports: Ipsen, Novartis, Pfizer, AAA, ITM
- Receipt of honoraria or consultation fees: Ipsen, Novartis, Pfizer, NovoNordisk, Ricordati
- Participation in a company sponsored speaker’s bureau: Ipsen Novartis, Pfizer, NovoNordisk, Ricordati
  • CIVES MAURO PICTURE

Mauro Cives

Italy
MD
Date | Session | Role

13 March/BS | Moderator

14 March/MC | Session 2A | Speaker
Discipline
Oncology
Institution
University of Bari "Aldo Moro"
Position
Senior Assistant Professor
Main Interest
  • Genomics of NENs
  • Adoptive T cell therapies
  • NEN clinical trials
Receipts of honoraria or consultation fees: IPSEN, AAA-Novartis, Advanz Pharma
Participation in a company sponsored speaker's bureau: IPSEN, AAA-Novartis, Advanz Pharma
  • Couvelard, Anne

Anne Couvelard

France 
MD, PhD
Date | Session | Role

13 March/BS | Moderator

14 March/MC | Session 1 | Moderator
Discipline
Pathology
Institution
AP-HP and Université Paris Cité
Position
Professor
Main Interest
  • Pathological and molecular characteristics of high grade neuroendocrine neoplasms
  • Molecular heterogeneity of neuroendocrine neoplasms
  • Diagnostic, prognostic and theranostic biomarkers in neuroendocrine neoplasms
I have no potential conflict of interest to declare.
  • CRINO STEFANO-FRANCESCO PICTURE

Stefano Francesco Crinò

Italy
MD. PhD
Date | Session | Role

14 March/MC | Session 4A | Speaker
Discipline
Gastroenterology
Institution
University Hospital of Verona
Position
Consultant
Main Interest
  • Treatment of pancreatic insulinoma: PI of a randomized controlled trial to compare endoscopic ultrasound-guided radio frequency ablation with surgical resection
  • Evaluation of the role of DAXX/ATRX evaluated by immunohistochemistry on endoscopic ultrasound specimens from non-functioning pancreatic neuroendocrine tumors
I have no potential conflict of interest to declare.
  • Croitoru

Adina Croitoru

Romania
Associate Prof
Date | Session | Role

13 March/PG | Session D | Moderator
Discipline
Oncology
Institution
Fundeni Clinical Institute, 258 Fundeni str, district 2
Position
Head of Department
Main Interest
  • Pancreatic Adenocarcinoma and Clonal Hematopoiesis
  • Gastrointestinal Neuroendocrine Tumors - Registry
  • Gastric Adenocarcinoma
I have the following potential conflict of interest to report:
Receipt of grants/research supports by me and my hospital: BMS, Exelixis, Astellas Pharma, Five Prime Terapeutics, Gilead Sciences, Canfite, Nanocarrier
Receipt of honoraria or consultation fees: Ipsen, Pfizer, MSD Oncology, Amgen, BMS, Sanofi, Roche, Novartis, Sandoz, Merck
Travel, accomodations, expenses: Merck, Servier, Ipsen
  • Cros

Jérôme Cros

France 
Pr
Date | Session | Role

13 March/BS | Moderator

13 March/BS | Session 3 | Speaker
Discipline
Pathology
Institution
Université Paris Cité - Hôpital Beaujon
Position
Professor
Main Interest
  • Neuroendocrine tumor molecular heterogeneity
  • Biomarkers
Participation in a company sponsored speaker's Bureau: Novartis / Esteve (sponsored seminars)
  • CUMMINS MEREDITH PICTURE

Meredith Cummins

Australia 
Date | Session | Role

15 March/MC | Session 5B - INCA | Speaker
Discipline
Nurse
Institution
NeuroEndocrine Cancer Australia
Position
CEO
Main Interest
  • Ensure education and awareness of NETs by HCPs is increased
  • Ongoing research is available in all countries especially Australia.
I have no conflicts of Interest to declare
  • DE-MESTIER LOUIS PICTURE

Louis de Mestier

France 
MD, PhD
Date | Session | Role

13 March/PG | Session D | Speaker & Panellist
Discipline
Gastroenterology
Institution
Beaujon Hospital, Université de Paris, Clichy, France
Position
Assistant Professor
Main Interest
  • Predictive and theranostic biomarkers in neuroendocrine tumors
  • Clinicopathological and molecular characterization of tumor heterogeneity in neuroendocrine tumors
  • Inherited predispositions to digestive neuroendocrine tumors
AAA/Novartis (consulting, lectures)
Esteve (consulting, research funding)
Ipsen (consulting)
Servier (consulting)
SIRTex (consulting)
Viatris (consulting)
  • DENECKE TIMM PICTURE

Timm Denecke

Germany
Prof. Dr. med.
Date | Session | Role

13 March/PG | Session B | Speaker
Discipline
Radiology
Institution
Universitätsklinikum Leipzig
Position
Head of Radiology
Main Interest
  • Oncologic Imaging including Nuclear Medicine
  • Interventional Oncology
  • Neuroendocrine Tumors
Honoraria and travel support from Siemens, Canon, Bayer for scientific lectures and meetings.
  • DEROOSE CHRISTOPHE PICTURE

Christophe Deroose

Belgium
M.D, Ph.D.
Date | Session | Role

15 March/MC | Session 5A | Speaker
Discipline
Nuclear medicine
Institution
KU Leuven
Position
Full Professor
Main Interest
  • PRRT
  • Somatostatin receptor PET
  • MFBG PET
Receipt of honoraria or consultation fees: Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, Terumo, PSI CRO, IRE. All paid to institution.
  • Frederic DESCHAMPS
    Frederic DESCHAMPS

Frédéric Deschamps

France 
MD, PhD
Date | Session | Role

13 March/PG | Session D | Speaker & Panellist
Discipline
Radiology
Institution
Gustave Roussy, Villejuif, France
Position
MD-PhD
Main Interest
  • Interventional radiology
  • Trans-arterial chemoembolization
  • bone metastases
Receipt of honoraria or consultation fees: Terumo, General Electric, Medtronic, Boston Scientific, IGEA
  • DUCREUX MICHEL PICTURE

Michel Ducreux

France 
MD, PhD
Date | Session | Role

14 March/MC | Session 3A | Moderator
Discipline
Oncology
Institution
Gustave Roussy
Position
Head of Gastorintestinal Unit, department of Medical Oncology
Main Interest
  • Gastroenteropancreatic Neuroendocrine Tumours
  • Drug Therapy
Receipt of grants/research supports: ROCHE, KEOCYT,
Receipt of honoraria or consultation fees: Roche, Servier, MSD, Pierre Fabre, MSD, Merck Serono, Ipsen, Bayer,
Participation in a company sponsored speaker’s bureau: Servier, Bayer, MSD, Pierre Fabre
Spouse/partner: My spouse is Head of the Oncology Business Unit SANDOZ France
  • Faggiano

Antongiulio Faggiano

Italy
MD, PhD
Date | Session | Role

14 March/MC | Session 1 | Moderator
Discipline
Endocrinology
Institution
Sapienza University of Rome
Position
Associate Professor
Main Interest
  • Molecular mechanisms of disease progression in NEN: NGS analysis of blood samples
  • Clinical study on therapy with somatostatin analogues in NEN and sequence of treatments
  • Clinical study on quality of life in NEN (endocrine-metabolic profile, nutrition, psyschological aspects)
I have the following potential conflict of interest to report:
Other support: Ipsen and Triple AAA (Novartis) Support to the University Department for research project
  • Falconi

Massimo Falconi

Italy
Prof. Falconi
Date | Session | Role

14 March/MC | Session 4A | Speaker

14 March/MC | Roundtable | Panellist
Discipline
Surgery
Institution
"Vita e Salute" University, IRCCS San Raffaele Hospital
Position
Full Professor of Surgery
Main Interest
  • Pancreatic surgery
  • Neuroendocrine GEP NEN
  • Pancreatic ductal adenocarcinoma
I have no potential conflict of interest to report
  • Fazio

Nicola Fazio

Italy
M.D., Ph.D.
Date | Session | Role

13 March/PG | Session C | Moderator
Discipline
Oncology
Institution
European Institute of Oncology
Position
Director of Division and Program
Main Interest
  • Neuroendocrine neoplasms
  • Upper GI cancers
  • Hepato-pancreato-biliary cancers
Receipt of grants/research supports: Ipsen, Merck, AAA, MSD.
Receipt of honoraria or consultation fees: AAA, Merck, MSD, Novartis, Pfizer, Boehringer, Ipsen.
  • Fernandez Cuesta

Lynnette Fernandez-Cuesta

France 
PhD
Date | Session | Role

13 March/BS | Session 1 | Moderator
Discipline
Tumor & cell biology
Institution
International Agency for Research on Cancer
Position
Team leader
Main Interest
  • Rare Cancers Genomics initiative (www.rarecancersgenomics.com)
  • Neuroendocrine tumors (lungNENomics project)
  • Mesothelioma (MESOMICS project)
I have no potential conflict of interest to report
  • Foto con bata 2020

Rocio Garcia-Carbonero

Spain
MD, PhD
Date | Session | Role

13 March/BS | Session 2 | Moderator

14 March/MC | Session 3A | Moderator

14 March/MC | Roundtable | Panellist
Discipline
Oncology
Institution
Hospital Universitario 12 de Octubre, Universidad Complutense of Madrid
Position
Head, GI and NE Oncology Unit, Oncology Department & Associate Professor of Medicine
Main Interest
  • New drug development in NETs and NECs
  • Development of biomarkers in NENs
  • Translational research
Receipt of grants/research supports: BMS; MSD, PFIZER
Receipt of honoraria or consultation fees: AAA-Novartis, Advanz Pharma, Amgen, Astellas, Bayer, BMS, Boerhringer, Esteve, GSK, Hutchmed, Ipsen, Merck, Midatech Pharma, MSD, PharmaMar, Pierre Fabre, Servier
Stock shareholder: None
Spouse/partner: Abbie, Astra Zeneca, Genomica, Gilead, Glaxo, Janssen, Lilly, Roche, Sanofi, Sysmex
  • GEILVOET WANDA PIC

Wanda Geilvoet

Netherlands
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Moderator
Discipline
Nurse
Institution
Erasmus MC, Rotterdam, The Netherlands
Position
Nurse practitioner, Endocrinology
Main Interest
  • Outpatient clinic for patients with neuroendocrine tumors and other endocrine cancers, patient coordinator and contact person in ENETS CoE
  • Active member tumor board for endocrine tumors and closely involved with the ENETS Center of Excellence audits
  • Vice-chair of ENETS Nurse & Dietician Group and member of medical advisory panel INCA
I have the following potential conflict of interest to report:

Receipt of honoraria or consultation fees: CORE2ED
  • GLASBERG SIMONA PICTURE

Simona Glasberg

Israel
Professor
Date | Session | Role

13 March/PG | Session C | Moderator

14 March/MC | Session 2A | Speaker
Discipline
Endocrinology
Institution
Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Israel
Position
Associate Professor of Medicine, Head of Neuroendocrine Tumor Unit, ENETS Center of Excellence, Division of Medicine
Main Interest
  • Enhancers and neuroendocrine neoplasms
  • Modulation of endocannabinoid system in neuroendocrine neoplasms
  • Theranostic in neuroendocrine neoplasms
Receipt of grants/research support and honoraria or consultation fees: Novartis/Triple A; Ipsen; SERB, CAMURUS
  • HACKENG WENZEL PICTURE

Wenzel Hackeng

Netherlands
PhD
Date | Session | Role

13 March/BS | Session 3 | Moderator
Discipline
Gastroenterology/Internal Medicine
Institution
University Medical Center Utrecht/Meander Medisch Centrum
Position
Resident doctor
Main Interest
  • Neuroendocrine tumors of the pancreas
  • Insulinoma
  • MEN1 syndrome
I have no potential conflict of interest to report
  • Julien HADOUX
    Julien HADOUX

Julien Hadoux

France 
MD, PhD
Date | Session | Role

14 March/MC | Session 3A | Speaker
Discipline
Oncology
Institution
Gustave Roussy
Position
Attending Physician
Main Interest
  • Neuroendocrine carcinoma
  • Precision medicine
  • Anaplastic thyroid carcinoma
I have the following potential conflict of interest to report:
Receipt of grants/research support: Novartis, IQVIA/Lilly
Receipt of honoraria or consultation fees: Lilly, IPSEN, Bayer, PharmaMAr, Roche, HRA pharma, AAA, EISAI
Participation in a company sponsored speaker’s bureau: None
Stock stakeholder: None
Spouse/partner: None
Other support (please specify)
  • HO TAK-WAI PICTURE

Tak-Wai Ho

United Kingdom
MSc
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Speaker
Discipline
Dietitian
Institution
Cambridge University Hospitals
Position
NEN and Diabetes Specialist Dietitian
Main Interest
  • Insulinomas
I have no potential conflict of interest to declare.
  • HOFLAND HANS PICTURE

Hans Hofland

Netherlands
Date | Session | Role

13 March/PG | Session A | Speaker
Discipline
Endocrinology
Institution
Erasmus MC
Position
Endocrinologist, Head of ENETS Center of Excellence
Main Interest
  • Functional NET syndromes
  • Radionuclide therapy
I have the following potential conflict of interest to report:

Receipt of honoraria or consultation fees: Ipsen, Novartis, Serb
  • JERVIS NICOLA PICTURE

Nicola Jervis

United Kingdom
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Speaker
Discipline
Nurse
Institution
Neuroendocrine Cancer UK
Position
Specialist Nurse: Support Service & Education Lead
Main Interest
  • Patient Involvement & Advocacy
  • Psychological Well-Being
  • Health & Identity
I have no potential conflict of interest to declare.
  • GRIGORIOS KALTSAS PICTURE

Gregory Kaltsas

Greece
Professor
Date | Session | Role

14 March/MC | Session 1 | Speaker
Discipline
Endocrinology
Institution
National and Kapodistrian University of Athens, Greece
Position
Professor
Main Interest
  • Inherited Endocrine Syndromes
  • Bone metastases in neuroendocrine tumors
  • Gastric Neuroendocrine neoplasms
Receipt of grants/research supports: IPSEN / PFIZER / FARAN / BIOKOSMOS / SANOFI
Receipt of honoraria or consultation fees: IPSEN
  • KASAJIMA ATSUKO PICTURE

Atsuko Kasajima

Germany
MD. PhD.
Date | Session | Role

15 March/MC | Session 6 | Speaker
Discipline
Pathology
Institution
Technical University Munich
Position
Pathologist
Main Interest
  • Pancreas NET
  • Pulmonary NET
  • Other NET
I have no potential conflict of interest to report
  • KJAER ANDREAS PICTURE

Andreas Kjaer

Denmark
MD, PhD
Date | Session | Role

13 March/BS | Session 4 | Moderator

15 March/MC | Session 5A | Moderator & Speaker
Discipline
Nuclear medicine
Institution
Rigshospitalet & University of Copenhagen
Position
Professor, chief physician
Main Interest
  • Molecular imaging of neuroendocrine tumors
  • Theranostics and targeted radionuclide therapy in NET
Co-founder of Curasight, Inventor/IPR on 64Cu-DOTATATE
  • Klöppel2

Günter Klöppel

Germany
Professor
Date | Session | Role

13 March/BS | Session 1 | Moderator
Discipline
Pathology
Institution
Dept of Pathology, Consultation Center for Pancreas and Endocrine Tumors, TU München, Germany
Position
Consultant and Professor emeritus
Main Interest
  • High grade NENs
  • Heterogeneity in pulmonary NENs
  • NEN mimickers
I have no potential conflict of interest to declare.
  • KNIGGE ULRICH PICTURE

Ulrich Knigge

Denmark
MD, DMSc
Date | Session | Role

13 March/PG | Poster Session - CS | Moderator

14 March/MC | Session 2B | Moderator
Discipline
Surgery
Institution
Depts. Surgery and Endocrinology, Rigshospitalet, Copenhagen University
Position
Associate Professor
Main Interest
  • Small initestinal NET
  • Appendiceal NET
  • Neuroendocrine carcinomas and NET G3
No Conflict of Interest
  • KOLAROVA TEODORA PIC

Teodora Kolarova

Bulgaria
Ms
Date | Session | Role

15 March/MC | Session 5B - INCA | Speaker
Discipline
Patient / Patient Advocat
Institution
International Neuroendocrine Cancer Alliance
Position
Executive Director
Main Interest
I have the following potential conflict of interest to report:
Receipt of grants/research support:
INCA has received institutional grants
from the following companies:
Novartis, AAA, Ipsen, ITM, Camurus,
Curium, SERB Pharmaceuticals,
RayzeBio, Esteve.
  • KOS-KUDLA BEATA PICTURE

Beata Kos-Kudła

Poland
MD, PhD, Prof.
Date | Session | Role

13 March/PG | Session D | Panellist
Discipline
Endocrinology
Institution
Department of Endocrinology and Neuroendocrine Tumors
Position
Professor, Chair of the Department
Main Interest
  • Biomarkers in NET
  • Diagnosis and treatment of GEP NET
  • Lung NET
Receipt of honoraria or consultation fees: Merck, Ipsen, Novartis, Pfizer.
Participation in a company sponsored speaker’s bureau: Merck, IBSA, Ipsen, Novartis, Pfizer.
  • KOSSATZ SUSANNE PICTURE

Susanne Kossatz

Germany
PhD
Date | Session | Role

13 March/BS | Session 4 | Speaker
Discipline
Nuclear medicine
Institution
Klinikum rechts der Isar at Technical University of Munich
Position
Assistant Professor (Tenure track)
Main Interest
  • Theranostics
  • Targeted drug delivery
  • Mechanisms of PRRT toxicity
I have the following potential conflict of interest to report:
Receipt of grants/research support: Research support from ITM Isotope Technologies Munich SE and Trimt GmbH for projects unrelated to the topic of the talk.
Receipt of honoraria or consultation fees: Speaker honoraria ITM Isotope Technologies Munich SE
  • KOUMARIANOU ANNA PIC

Anna Koumarianou

Greece
MD PhD
Date | Session | Role

13 March/PG | Session A | Moderator

14 March/MC | Roundtable | Panellist
Discipline
Oncology
Institution
Fourth Department of Internal Medicine, National and Kapodistrian University of Athens Greece
Position
Head of Hematology Oncology Unit
Main Interest
  • Lung Neuroendocrine Tumors
  • miRNA biomarkers
  • Clinical Trials in high-grade tumors
I have the following potential conflict of interest
Educational Grants:
Ipsen Greece,
Faran Greece,
Pfizer Greece
  • LAMARCA ANGELA PICTURE

Angela Lamarca

Spain
MD, PhD, MSc
Date | Session | Role

14 March/MC | Session 3A | Speaker
Discipline
Oncology
Institution
Fundacion Jimenez Diaz University Hospital
Position
Consultant Medical Oncologist
Main Interest
  • Systemic treatment for NENs
  • Development of predictive and prognostic biomarkers in NENs
  • Management of carcinoid syndrome and associated complications
Travel and educational support from Ipsen, Pfizer, Bayer, AAA, SirtEx, Novartis, Mylan, Delcath Advanz Pharma and Roche.
Speaker honoraria from Merck, Pfizer, Ipsen, Incyte, AAA/Novartis, QED, Servier, Astra Zeneca, EISAI, Roche, Advanz Pharma and MSD.
Advisory and consultancy honoraria from EISAI, Nutricia, Ipsen, QED, Roche, Servier, Boston Scientific, Albireo Pharma, AstraZeneca, Boehringer Ingelheim, GENFIT, TransThera Biosciences, Taiho and MSD.
Principal Investigator-associated Institutional Funding form QED, Merck, Boehringer Ingelheim, Servier, Astra Zeneca, GenFit, Panbela Therapeutics, Novocure GmbH, Camurus AB, Albireo Pharma, Taiho, TransThera and Roche.
Member of the Knowledge Network and NETConnect Initiatives funded by Ipsen.
  • LINES KATE PICTURE

Kate Lines

United Kingdom
Date | Session | Role

13 March/BS | Session 3 | Speaker
Discipline
Tumor & cell biology
Institution
University of Oxford
Position
Research Fellow
Main Interest
  • Neuroendocrine tumours
  • Multiple Endocrine Neoplasia Type 1
  • Epigenetics
I have no potential conflict of interest to report
  • LUGAT

Alexandre Lugat

France 
MD
Date | Session | Role

13 March/BS | Session 4 | Speaker
Discipline
Oncology
Institution
Nantes University Hospital
Position
Endocrine Oncologist
Main Interest
  • Neuroendocrine tumors
  • Endocrine oncology
  • targeted radionuclide therapy
I have no potential conflict of interest to declare.
  • LUONG TU-VINH PICTURE

Tu Vinh Luong

United Kingdom
Dr
Date | Session | Role

13 March/PG | Session B | Speaker
Discipline
Pathology
Institution
Royal Free London NHS Foundation Trust
Position
Consultant Histopathologist
Main Interest
  • NETFR: Fibrosis scoring of mesenteric mass in patient with small bowel NETs + tissue banking for ECM epigenetic analysis
  • G3 GEPNEC: Examining the genetic and epigenetic landscape of gastroenteropancreatic neuroendocrine carcinoma
I have no potential conflict of interest to report
  • MARINONI ILARIA PICTURE

Ilaria Marinoni

Switzerland
PhD
Date | Session | Role

13 March/BS | Moderator

13 March/BS | Session 3 | Speaker
Discipline
Tumor & cell biology
Institution
Institute of Pathology
Position
Group Leader
Main Interest
  • Studying epigenetic changes occurring along Pancreatic Neuroendocrine Tumor progression.
  • Establishing an in vitro model of PanNET for precision medicine
I have no potential conflict of interest to report
  • MARTIN WENDY PICTURE

Wendy Martin

United Kingdom
MSc, BSc (hons), RGN
Date | Session | Role

14 March/MD | Session 4B - Nurse Symposium | Moderator
Discipline
Nurse
Institution
Kings College Hospital Foundation Trust. UK
Position
Lead NET clinical nurse specialist
Main Interest
  • Quality of Life
  • Carcinoid heart disease
  • Education
Speakers fees from the following companies:
Ipsen
Advanced Accelerator Applications
  • MCDONNELL MARK PIC

Mark McDonnell

Ireland
Mr
Date | Session | Role

14 March/MC | Roundtable | Panellist

15 March/MC | Session 5B - INCA | Speaker
Discipline
Patient / Patient Advocat
Institution
International Neuroendocrine Cancer Alliance
Position
President
Main Interest
  • Patient advocacy and engagement
  • Treatment options
  • Patient pathway
INCA receives support from Ipsen, Advanced Accelerator Applications, Victory NET, ITM, SERB Pharmaceuticals, RayzeBio, Camurus, Curium.
  • MCNAMARA MAIREAD PICTURE

Mairead McNamara

United Kingdom
MB PhD
Date | Session | Role

13 March/PG | Session D | Speaker
Discipline
Oncology
Institution
University of Manchester/The Christie
Position
Senior Lecturer/Honorary Consultant
Main Interest
  • CI for NET-02: A randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
  • Clinical supervisor for PhD: DISSECTING THE NEUROENDOCRINE LANDSCAPE OF EXTRA-PULMONARY NEUROENDOCRINE CARCINOMA TO DISCOVER BIOMARKERS WITH CLINICAL UTILITY
  • Methylation analysis of samples from NET-02
I have the following potential conflict of interest to report:

Receipt of grants/research support: Ipsen, NuCana, Servier, Astra Zeneca
Receipt of honoraria or consultation fees: Incyte, Astra Zeneca
Participation in a company sponsored speaker’s bureau: Astra Zeneca, AAA
Stock stakeholder: None
Spouse/partner: NA
Other support (please specify): NA
  • MONDINO ANNA PICTURE

Anna Mondino

Italy
PhD
Date | Session | Role

13 March/BS | Session 2 | Speaker
Discipline
Immunology, Cancer Immunotherapy
Institution
IRCCS San Raffaele Scientific Institute
Position
Head of Lymphocyte Activation Unit
Main Interest
  • Adoptive T cell therapy
  • CAR-T cell therapy of pancreas adenocarcinoma
  • Radio-immunotherapy of solid tutors
I have no potential conflict of interest to declare.
  • Munk Plum

Lise Munk Plum

Denmark
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Moderator
Discipline
Nurse
Institution
Copenhagen University, Rigshospitalet
Position
Clinical nurse specialist
Main Interest
I have no potential conflict of interest to declare.
  • NIEVEEN-VAN-DIJKUM ELS PICTURE

Els Nieveen van Dijkum

Netherlands
Prof Dr
Date | Session | Role

13 March/PG | Session C | Speaker
Discipline
Surgery
Institution
Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, The Netherlands
Position
Chair ENETS COE Amsterdam UMC
Main Interest
  • Pancreatic NET - Risk stratification for recurrence, wait and see in small pNET, surgical outcomes and Quality of Life
  • Small bowel NET - Surgical approach, fluorescence, treatment planning
  • Training and education - Training residents and surgeons, nurses and patients
I have no potential conflict of interest to declare.
  • NONNEKENS JULIE PICTURE

Julie Nonnekens

Netherlands
PhD
Date | Session | Role

13 March /BS | Session 4 | Speaker
Discipline
Tumor & cell biology
Institution
Erasmus Medical Center Rotterdam
Position
Associate Professor
Main Interest
  • Radionuclide therapy
  • Radiobiology
  • DNA damage response
I have the following potential conflict of interest to report:
Receipt of grants/research support: Quirem Medical, a Terumo company; POINT Biopharma
Receipt of honoraria or consultation fees: Novartis
  • Otoole-profile

Dermot O'Toole

Ireland
MD
Date | Session | Role

14 March/MC | Session 4A | Moderator

15 March/MC | Session 5B - INCA | Speaker
Discipline
Gastroenterology
Institution
St Vincent’s University & St James Hospitals & Trinity College, Dublin
Position
Professor in Gastroenterology & National Clinical Lead in NET
Main Interest
  • Digestive neuroendocrine tumours
  • Barrett's oesophagus (Dx and treatment)
  • Familial pancreatic cancer
None received in last three years.
Previous disclosed in COI form uploaded
  • PANZUTO FRANCESCO PICTURE

Francesco Panzuto

Italy
MD, PhD
Date | Session | Role

13 March/PG | Moderator

13 March/PG | Session C | Speaker
Discipline
Gastroenterology
Institution
Sant'Andrea University Hospital, Rome Italy
Position
Assistant Professor of Gastroenterology, Sapienza University of Rome, Digestive Disease Unit, Coordinator ENETS Center of Excellence of Rome (Sant'Andrea site)
Main Interest
  • Gastric Neuroendocrine Neoplasia
  • NEN epidemiology (national registry - database)
  • Prognostic features and risk factros for NEN progression
I have no potential conflict of interest to declare.
  • PAPE ULRICH-FRANK PICTURE

Ulrich-Frank Pape

Germany
MD
Date | Session | Role

14 March/MC | Life Achievement Award | Laudator
Discipline
Gastroenterology
Institution
Asklepios Klinik St. Georg, Asklepios Medical School, Asklepios Tumorzentrum Hamburg, Germany
Position
Department Head
Main Interest
  • Neuroendocrine Tumor treatment and epidemiology
  • GI hormone physiology
  • GI peptide hormone treatment
Speaker honoraria for AAA/Novartis Pharma and Ipsen Pharma
Research funding by AAA/Novartis Pharma and Ipsen Pharma
  • PARTELLI STEFANO PICTURE

Stefano Partelli

Italy
Prof
Date | Session | Role

13 March/PG | Session D | Speaker & Panellist
Discipline
Surgery
Institution
Vita-Salute San Raffaele University
Position
Associate Professor of Surgery
Main Interest
  • Surgical treatment of GEP-NEN
  • Management of asymptomatic small Pan-NET
  • Preoperative therapy for advanced GEP-NEN
I have no potential conflict of interest to declare.
  • Ok Pascher 300dpi

Andreas Pascher

Germany
MD, PhD
Date | Session | Role

14 March/MC | Session 4A | Speaker
Discipline
Surgery
Institution
UKM Muenster, Dept. of General, Visceral and Transplant Surgery
Position
Professor of Surgery, Head of Department
Main Interest
  • MJC EBNEN
  • Liver Surgery for NEN liver metastasis
  • GI NEN
Receipt of honoraria or consultation fees: Ipsen, Novartis
  • Patocs

Attila Patócs

Hungary
Prof. Dr.
Date | Session | Role

14 March/MC | Session 1 | Speaker
Discipline
medical genetics, moloecular and cancer genetics
Institution
National Institute of Oncology
Position
head of department
Main Interest
  • hereditary cancer syndromes
  • neuroendocrine tumours
  • targeted therapies
I have no potential conflict of interest to declare.
  • Pavel App

Marianne Pavel

Germany
Prof. Dr.
Date | Session | Role

14 March/MC | Session 2A | Speaker

14 March/MC | Roundtable | Panellist

15 March/MC | Session 5A | Moderator
Discipline
Endocrinology
Institution
Universitätsklinikum Erlangen
Position
Senior Physician and Chair of Endocrinology, ENETS Vice Chair
Main Interest
  • Precision oncology in NEN
  • Novel targeted treatment in NEN
  • High grade NEC
Receipt of honoraria or consultation fees: Novartis / AAA, Ipsen, Riemser, Boehringer-Ingelheim, MSD, Lilly, Hutchmed, Recordati, Serb
  • PERREN AUREL PICTURE

Aurel Perren

Switzerland
Prof
Date | Session | Role

13 March/BS | Session 1 | Speaker
Discipline
Pathology
Institution
Institute of Tissue medicine and Pathology, University of Bern
Position
Director
Main Interest
  • The role of epigenetics and metabolism in the progression of Pancreatic Neuroendocrine Tumors (PanNET)
  • Tumoroids / Organoids as models for PanNET
  • Pathological and molecular classification of endocrine tumors
I have the following potential conflict of interest to report:

Receipt of honoraria or consultation fees: Novartis
Stock stakeholder: Roche Sandoz
  • PITFIELD DEBORAH PICTURE

Deborah Pitfield

United Kingdom
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Moderator
Discipline
Nurse
Institution
Cambridge University Hospitals , Addenbrookes, Cambridge
Position
NET specialist Nurse
Main Interest
  • NET. Pheochromocytomas and Paragangliomas
Receipt of honoraria or consultation fees: AAA Novartis
  • POIANA CATALINA PICTURE

Catalina Poiana

Romania
MD, PhD, Professor of Endocrinology
Date | Session | Role

14 March/MC | Roundtable | Panellist
Discipline
Endocrinology
Institution
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Position
Professor of Endocrinology, Vice-Rector
Main Interest
  • Endocrine tumors
  • Menopause and Osteoporosis
  • Ageing
Invited speaker for Ipsen Pharma Romania SRL, AMGEN Romania SRL, SC Pfizer Romania SRL, Novo Nordisk Romania
  • QUAGLIA ELIZABETH PICTURE

Elizabeth Quaglia

United Kingdom
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Speaker
Discipline
Nurse
Institution
Royal Free London NHS Foundation Trust
Position
Lead Nurse - Neuroendocrine Tumours
Main Interest
I have received honaoraria for speaking from IPSEN and AAA (NOVARTIS)
  • RAD

Roland Rad

Germany
MD
Date | Session | Role

13 March/BS | Session 1 | Speaker
Discipline
Tumor & cell biology
Institution
Technical University of Munich
Position
Professor, Institute Director
Main Interest
I have no potential conflict of interest to declare.
  • RAMAGE JOHN PICTURE

John Ramage

United Kingdom
Professor
Date | Session | Role

15 March/MC | Session 6 | Speaker
Discipline
Gastroenterology
Institution
King's Health Partners and Hampshire Hospitals Foundation Trust
Position
Consultant Gastroenterologist and Hepatologist
Main Interest
  • Quality of life and symptoms scores in neuroendocrine tumours of the small bowel and liver
  • Rectal NET endoscopic therapy
  • UK NET registry data epidemiology
I have no potential conflict of interest to declare.
  • REED NICHOLAS-S PIC

Nicholas Reed

United Kingdom
Prof.
Date | Session | Role

15 March/MC | Session 6 | Moderator

15 March/MC | Awards Ceremony | Moderator
Discipline
Oncology
Institution
Beatson Oncology Centre/Gartnavel General Hospital
Position
Consultant Oncologist
Main Interest
  • PRRT,
  • New chemotherapy/medical treatments
  • New treatment approaches
Receipt of honoraria or consultation fees: Ipsen, Novartis, Esteve
Participation in a company sponsored speaker's bureau: Novartis
  • RINDI GUIDO PICTURE

Guido Rindi

Italy
M.D., Ph.D
Date | Session | Role

13 March/PG | Poster Session - BS | Moderator

14 March/MC | Session 3B | Moderator
Discipline
Pathology
Institution
Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore
Position
Professor of Pathology
Main Interest
  • NEN
  • GI
  • Lung
AAA speker bureau; Bracco Imaging Suisse, consultation fees.
  • RINKE ANJA PICTURE

Anja Rinke

Germany
PD Dr
Date | Session | Role

13 March/PG | Session C | Speaker
Discipline
Gastroenterology
Institution
UKGM, Marburg / Philipps University Marburg
Position
Consultant
Main Interest
  • GEP NEN, clinical trials, prognostic parameters
  • Lung NETs
Research/clinical trials: Novartis GmbH; IPSEN Pharma
GmbH, ITM Solucion GmbH

Honoraria for presentations/advisory board attendance: Advanz Pharma,
Esteve Pharmaceuticals GmbH, Falk Foundation e.V., IPSEN Pharma,
Novartis Radiopharmaceuticals GmbH

Non financial COIs: Membership BDI, DGVS, Deutsche Krebsgesellschaft, ESMO, Board of the German NET Registry, AIO, ENETS (until 5/23 Advisory Board)
  • Ruszniewski

Philippe Ruszniewski

France 
Prof
Date | Session | Role

14 March/MC | Roundtable | Moderator & Speaker
Discipline
Gastroenterology
Institution
Université Paris Cité and Beaujon Hospital, Clichy
Position
Professor of Gastoenterology-Pancreatology, Dean of Medicine Faculty Université Paris Cité
Main Interest
  • NET epidemiology
  • NET treatment
  • Translational medicine
Scientific Advisor to AAA and Ipsen
  • SADANANDAM ANGURAJ PICTURE-small

Anguraj Sadanandam

United Kingdom
PhD
Date | Session | Role

13 March/BS | Session 2 | Moderator
Discipline
Tumor & cell biology
Institution
Institute of Cancer Research (ICR), London
Position
Reader in Stratified and Precision Cancer Medicine
Main Interest
  • Genomics
  • Personalised Medicine
  • Immunotherapy
Advisor - Diagnostring Laboratories and Enedra Therapeutics
Co-Founder - Oncoassign
  • Santos Ana Paula

Ana Santos

Portugal
PhD
Date | Session | Role

13 March/PG | Poster Session - CS | Moderator

14 March/MC | Session 2B | Moderator
Discipline
Endocrinology
Institution
Porto Portuguese Institute of Oncology (IPOFG Porto)/ Porto Comprehensive Cancer Center (P.CCC)
Position
Endocrinology Consultant
Main Interest
  • Neuroendocrine Tumors
  • Metabolic Syndrome and Cancer
  • Association between Obesity and MetS with Neuroendocrine Tumors
I have no potential conflict of interest to declare.
  • SIMBOLO MICHELE PICTURE

Michele Simbolo

Italy
PhD
Date | Session | Role

13 March/BS | Session 1 | Speaker
Discipline
Pathology
Institution
University of Verona
Position
Temporary Assistant Professor
Main Interest
I have no potential conflict of interest to report
  • SMITH STACEY PICTURE

Stacey Smith

United Kingdom
Neuroendocrine Clinical Nurse Specialist
Date | Session | Role

14 March/MC | Session 4B - Nurse Symposium | Speaker
Discipline
Nurse
Institution
Queen Elizabeth Hospital Birmingham, part of University Hospitals Birmingham NHS Foundation Trust
Position
Lead Clinical Nurse Specialist
Main Interest
  • Current United Kingdom and Ireland Neuroendocrine Tumour Society (UKINETS) Nurse Representative and is a member of the Midlands Cancer Alliance NET Expert Advisory Group.
  • Development of the UK’s National Liver Transplantation in NETs Programme and is a core member of the National Multidisciplinary Team Meeting
  • Member of the UKINETS CHD consensus steering group
I have the following potential conflict of interest to report:

Receipt of honoraria or consultation fees: Novartis, AAA and Ipsen
Participation in a company sponsored speaker’s bureau: Novartis, AAA and Ipsen
  • SPADA FRANCESCA PICTURE

Francesca Spada

Italy
M.D., Ph.D
Date | Session | Role

14 March/MC | Session 2A | Speaker
Discipline
Oncology
Institution
European Institute of Oncology (IEO), IRCCS, Milan, Italy
Position
Medical Oncologist (M.D., Ph.D)
Main Interest
  • Management and development of predictive and prognostic biomarkers in high grade NENs and mixed NENs
  • Chemotherapy in NENs
  • Management of functioning NETs
Personal financial interests:
Advisory board, public speaking: Ipsen, Advanced Accelerator Applications, MSD/ Merck, Hutchmed

Institutional financial interests:
Clinical trials (P.I.): GETNE, Incyte, MSD

Non-financial interests:
AIOM: coordinator of neuroendocrine neoplasms guidelines
ITANET: member of the scientific board
ESMO: member of the NETs and Endocrine Tumours faculty
  • SPEEL EJM PICTURE

Ernst-Jan Speel

Netherlands
PhD (Prof. Dr.)
Date | Session | Role

13 March/PG | Poster Session - BS | Moderator

14 March/MC | Session 3B | Moderator
Discipline
Pathology
Institution
Maastricht UMC
Position
Head Molecular Diagnostics, Department of Pathology
Main Interest
  • Lung NENs
  • Molecular tumor diagnostics
  • Biomarkers for cancer diagnosis, prognosis and therapy selection
Receipt of grants/research supports: Pfizer, Bayer
  • SRIRAJASKANTHAN RAJ PICTURE

Raj Srirajaskanthan

United Kingdom
Dr
Date | Session | Role

13 March/PG | Session C | Speaker
Discipline
Gastroenterology
Institution
Kings College Hospital, London
Position
Consultant Gastroenterologist
Main Interest
  • Epidemiology and prognosis of Neuroendocrine Neoplasms
  • Endoscopic characterisation of resection of NETs
  • Digital technology and integration to healthcare
I have the following potential conflict of interest to report:
Receipt of grants/research support: AAA/ Novartis
Receipt of honoraria or consultation fees: Ipsen, AAA, Novartis, ITM, Advanz
  • STALBERG PETER PICTURE

Peter Stalberg

Sweden
Professor
Date | Session | Role

14 March/MC | Session 4A | Speaker
Discipline
Surgery
Institution
Dept. of Surgery, Uppsala University Hospital, Sweden
Position
Professor and Consultant Endocrine Surgeon
Main Interest
  • Small-intestinal NET
  • Pancreatic NET
I have no conflicts of interest to declare
  • SUNDIN ANDERS PICTURE

Anders Sundin

Sweden
MD PhD Prof
Date | Session | Role

13 March/PG | Session B | Speaker

13 March/PG | Session D | Panellist
Discipline
Radiology
Institution
Uppsala University
Position
Professor Emeritus
Main Interest
  • PET/CT, PET/MRI and SPECT/CT in neuroendocrine and endocrine tumors • 68Ga-DOTATOC-PET/MRI
  • Pheochromocytama and paraganglioma
  • Optimization of PRRT
I have no potential conflict of interest to report
  • TESSELAAR MARGOT PICTURE

Margot Tesselaar

Netherlands
MD PhD
Date | Session | Role

13 March/PG | Session B | Speaker
Discipline
Oncology
Institution
Netherlands Cancer Institute
Position
Head of department of gastrointestinal oncology
Main Interest
  • Immunotherapy/chemotherapy
  • NEC/MCC
  • carcinoid heart disease
Receipt of grants/research supports: Merck BV
  • Thakker 19

Rajesh Thakker

United Kingdom
Professor of Medicine, MD, FRCP, FRS
Date | Session | Role

14 March/MC | Session 1 | Speaker
Discipline
Endocrinology
Institution
University of Oxford
Position
Professor of Medicine
Main Interest
  • Genetics
  • Neoplasia/cancer
  • epigenetics
Receipt of grants/research supports: Novo Nordisk, Novartis, BMS
  • THIRLWELL CHRISSIE PICTURE

Chrissie Thirlwell

United Kingdom
MD PhD
Date | Session | Role

14 March/MC | Session 3A | Speaker
Discipline
Oncology
Institution
University of Bristol
Position
Professor of Cancer Genomics
Main Interest
  • Integrated genomic analysis of neuroendocrine neoplasms
  • Epigenetics - DNA methylation
  • Molecular classification of neuroendocrine neoplasms
Conference travel support from Ipsen and Novartis.
  • TIENSUU-JANSON EVA PICTURE

Eva Tiensuu Janson

Sweden
MD PhD
Date | Session | Role

14 March/MC | Session 1 | Speaker

14 March/MC | Roundtable | Panellist

15 March/MC | Session 5B - INCA | Moderator

15 March/MC | Session 6 | Moderator

15 March/MC | Awards Ceremony | Moderator
Discipline
Endocrinology
Institution
Dept. of Medical Sciences, Uppsala University
Position
Professor
Main Interest
  • Small intestinal NETS
  • Neuroendocrine carcinomas
  • Genetics
Scientific Committee for Nordic NET, Ipsen. Paid to department
  • TOUMPANAKIS CHRISTOS PIC

Christos Toumpanakis

United Kingdom
Prof, MD, PhD, FRCP, AGAF, FEBGH
Date | Session | Role

13 March/PG | Session B | Moderator

14 March/MC | Session 2A | Moderator
Discipline
Gastroenterology
Institution
NET Unit Royal Free Hospital London
Position
Professor of Gastroenterology and NETs - University College of London
Main Interest
  • Carcinoid Heart Disease
  • Novel blood and imaging biomarkers
  • Mesenteric fibrosis
I will participate at AAA Satellite Symposium on 14/3/2024.

Receipt of grants/research supports: AAA, IPSEN
Receipt of honoraria or consultation fees: AAA, IPSEN
Participation in a company sponsored speaker's bureau: AAA, IPSEN
  • VALK GERLOF PICTURE

Gerlof Valk

Netherlands
M.D. Ph.D.
Date | Session | Role

14 March/MC | Session 1 | Speaker
Discipline
Endocrinology
Institution
University Medical Center Utrecht
Position
Professor of endocrinology
Main Interest
No conflicts of interest
  • VAN-VELTHUYSEN MARIE-LOUISE PICTURE

Marie-Louise van Velthuysen

Netherlands
MD, PhD
Date | Session | Role

13 March/PG | Session B | Moderator
Discipline
Pathology
Institution
Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands
Position
Attending Pathologist
Main Interest
  • Classification of NEN G3
  • Appendiceal Neoplasms
I have no potential conflict of interest to report
  • WALTER THOMAS PICTURE

Thomas Walter

France 
PhD, MD
Date | Session | Role

14 March/MC | Session 2A | Speaker
Discipline
Gastroenterology
Institution
Hospices Civils of Lyon
Position
Professor
Main Interest
  • Systemic treatments of NEN
  • Leading some clinical trials (NIPINEC, BEVANEC, MGMT-NET...)
  • Metastatic lung carcinoid tumors
Receipt of grants/research supports: Ipsen, AdAcAp, BIODENA
Receipt of honoraria or consultation fees: Terumo, AdAcAp, Esteve. Incyte
  • Welin

Staffan Welin

Sweden
MD,PhD
Date | Session | Role

14 March/MC | Session 2A | Moderator
Discipline
Endocrinology
Institution
Endocrine Oncology Uppsala
Position
Head of Department
Main Interest
  • PRRT
  • GEPNETS
  • MEN1
Receipt of honoraria or consultation fees: AAA, Ipsen, Serb Pharma
  • WIEDENMANN BERTRAM PICTURE

Bertram Wiedenmann

Germany
Prof. Dr. med.
Date | Session | Role

14 March/MC | Life Achievement Award | Recipient
Discipline
Tumor & cell biology
Institution
Charite Universitätsmedizin Berlin
Position
Senior Professor, Head of NET Research, ENETS CoE Charite
Main Interest
  • Molecular profiling of NET entity subgroups
  • Clinical trials
  • Tumor and cell biology
I have the following potential conflict of interest to report:
Stock stakeholder:
- Autem Therapeutics, Hanover, NH. USA
- 3B Pharamceuticals, Berlin, Germany
  • ZERINI DARIO PICTURE

Dario Zerini

Italy
Dr.
Date | Session | Role

13 March/PG | Session D | Speaker & Panellist
Discipline
Radiotherapy
Institution
European Institute of Oncology (Milan)
Position
Staff Physician
Main Interest
  • Stereotactic radiotherapy
  • Radiobiology of NET tumor
I have no potential conflict of interest to report